ESR2 and polycystic ovary syndrome: As shown in Figure 5B, the staining intensity of ERβ was significantly decreased in untreated PCOS rats compared with normal control rats (22.80 ± 0.32% vs. 5.15 ± 0.25%, p < 0.05).